Colorectal Cancer Clinical Trials in Chicago

Showing 161-177 of 177 trials

Dignity Therapy in mCRC to Increase Peaceful Awareness & Impact Goals of Care Decision-Making

NCT01074385

The purpose of this study is to try and improve the way that patients with colon cancer understand and cope with their illness and give them tools for talking with their loved ones and family about their illness.

Stage IV Colorectal Cancer

Northwestern University24 participantsStarted Apr 2010

Chicago, Illinois, United States

COMPLETEDPHASE22.2 miles

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer

NCT00006786

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Bevacizumab may stop the growth of colorectal cancer by stopping blood flow to the tumor. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy plus bevacizumab in treating patients who have advanced colorectal cancer.

Colorectal Cancer

Eastern Cooperative Oncology GroupStarted Nov 2000

Scottsdale, Arizona, United States • Duarte, California, United States • Palo Alto, California, United States +74 more locations

Dignity Therapy in mCRC to Increase Peaceful Awareness & Impact Goals of Care Decision-Making

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer

Colorectal Cancer Trials in Other Cities

FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer

Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction

Colon Cancer Prevention Using Selenium

SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

S9923 R115777 in Treating Patients With Advanced Colorectal Cancer

Computer-Based Tailored or Standard Information for Colorectal Cancer Screening

GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer

Study of XL281 in Adults With Solid Tumors

Computerized Tomographic Colonography Compared With Standard Diagnostic Procedures in Detecting Colorectal Neoplasia

Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer

Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic Cancer

Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer

Other Conditions in Chicago